These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 8847001)

  • 1. An alternative strategy to the use of guinea pigs for the identification of skin sensitization hazard.
    Basketter DA; Scholes EW; Chamberlain M; Barratt MD
    Food Chem Toxicol; 1995 Dec; 33(12):1051-6. PubMed ID: 8847001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skin sensitization testing in potency and risk assessment.
    Kimber I; Basketter DA; Berthold K; Butler M; Garrigue JL; Lea L; Newsome C; Roggeband R; Steiling W; Stropp G; Waterman S; Wiemann C
    Toxicol Sci; 2001 Feb; 59(2):198-208. PubMed ID: 11158712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preclinical skin sensitization testing of antihistamines: guinea pig and local lymph node assay responses.
    Robinson MK; Cruze CA
    Food Chem Toxicol; 1996 May; 34(5):495-506. PubMed ID: 8655100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the skin sensitizing potential of unsaturated compounds as assessed by the murine local lymph node assay (LLNA) and the guinea pig maximization test (GPMT).
    Kreiling R; Hollnagel HM; Hareng L; Eigler D; Lee MS; Griem P; Dreessen B; Kleber M; Albrecht A; Garcia C; Wendel A
    Food Chem Toxicol; 2008 Jun; 46(6):1896-904. PubMed ID: 18343554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-animal assessment of skin sensitization hazard: Is an integrated testing strategy needed, and if so what should be integrated?
    Roberts DW; Patlewicz G
    J Appl Toxicol; 2018 Jan; 38(1):41-50. PubMed ID: 28543848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of the local lymph node assay in the evaluation of the sensitizing potential of pharmaceutical process intermediates.
    Durand G; de Burlet G; Virat M; Nauman BD
    Contact Dermatitis; 2003 Sep; 49(3):148-54. PubMed ID: 14678211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of the skin sensitization potency of eugenol and its dimers using a non-radioisotopic modification of the local lymph node assay.
    Takeyoshi M; Noda S; Yamazaki S; Kakishima H; Yamasaki K; Kimber I
    J Appl Toxicol; 2004; 24(1):77-81. PubMed ID: 14745850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of skin sensitization assays.
    Basketter DA; Chamberlain M
    Food Chem Toxicol; 1995 Dec; 33(12):1057-9. PubMed ID: 8847002
    [No Abstract]   [Full Text] [Related]  

  • 9. Nothing is perfect, not even the local lymph node assay: a commentary and the implications for REACH.
    Basketter DA; McFadden JF; Gerberick F; Cockshott A; Kimber I
    Contact Dermatitis; 2009 Feb; 60(2):65-9. PubMed ID: 19207375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skin sensitisation testing--new perspectives and recommendations.
    Steiling W; Basketter D; Berthold K; Butler M; Garrigue JL; Kimber I; Lea L; Newsome C; Roggeband R; Stropp G; Waterman S; Wiemann C
    Food Chem Toxicol; 2001 Apr; 39(4):293-301. PubMed ID: 11295477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Updating the skin sensitization in vitro data assessment paradigm in 2009.
    Basketter DA; Kimber I
    J Appl Toxicol; 2009 Aug; 29(6):545-50. PubMed ID: 19484705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skin sensitization potency of methyl methacrylate in the local lymph node assay: comparisons with guinea-pig data and human experience.
    Betts CJ; Dearman RJ; Heylings JR; Kimber I; Basketter DA
    Contact Dermatitis; 2006 Sep; 55(3):140-7. PubMed ID: 16918612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local lymph node assay: validation assessment for regulatory purposes.
    Gerberick GF; Ryan CA; Kimber I; Dearman RJ; Lea LJ; Basketter DA
    Am J Contact Dermat; 2000 Mar; 11(1):3-18. PubMed ID: 10684384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ICCVAM evaluation of the murine local lymph node assay. Conclusions and recommendations of an independent scientific peer review panel.
    Dean JH; Twerdok LE; Tice RR; Sailstad DM; Hattan DG; Stokes WS
    Regul Toxicol Pharmacol; 2001 Dec; 34(3):258-73. PubMed ID: 11754530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The local lymph node assay: current position in the regulatory classification of skin sensitizing chemicals.
    Basketter DA; Gerberick GF; Kimber I
    Cutan Ocul Toxicol; 2007; 26(4):293-301. PubMed ID: 18058304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In chemico, in vitro and in vivo comparison of the skin sensitizing potential of eight unsaturated and one saturated lipid compounds.
    Kreiling R; Gehrke H; Broschard TH; Dreeßen B; Eigler D; Hart D; Höpflinger V; Kleber M; Kupny J; Li Q; Ungeheuer P; Sauer UG
    Regul Toxicol Pharmacol; 2017 Nov; 90():262-276. PubMed ID: 28958912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of human contact allergens in the murine local lymph node assay.
    Ryan CA; Gerberick GF; Cruse LW; Basketter DA; Lea L; Blaikie L; Dearman RJ; Warbrick EV; Kimber I
    Contact Dermatitis; 2000 Aug; 43(2):95-102. PubMed ID: 10945748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sulphanilic acid: divergent results in the guinea pig maximization test and the local lymph node assay.
    Basketter DA; Scholes EW; Cumberbatch M; Evans CD; Kimber I
    Contact Dermatitis; 1992 Oct; 27(4):209-13. PubMed ID: 1451484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemical applicability domain of the Local Lymph Node Assay (LLNA) for skin sensitisation potency. Part 3. Apparent discrepancies between LLNA and GPMT sensitisation potential: False positives or differences in sensitivity?
    Roberts DW; Schultz TW; Api AM
    Regul Toxicol Pharmacol; 2016 Oct; 80():260-7. PubMed ID: 27477089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ICCVAM evaluation of the murine local lymph node assay. Data analyses completed by the National Toxicology Program Interagency Center for the Evaluation of Alternative Toxicological Methods.
    Haneke KE; Tice RR; Carson BL; Margolin BH; Stokes WS
    Regul Toxicol Pharmacol; 2001 Dec; 34(3):274-86. PubMed ID: 11754531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.